Compare CLDX & TPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLDX | TPB |
|---|---|---|
| Founded | N/A | 1988 |
| Country | United States | United States |
| Employees | N/A | 484 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Tobacco |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 1995 | 2015 |
| Metric | CLDX | TPB |
|---|---|---|
| Price | $29.61 | $87.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | $46.60 | ★ $115.00 |
| AVG Volume (30 Days) | ★ 644.2K | 456.8K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.39% |
| EPS Growth | N/A | ★ 45.33 |
| EPS | N/A | ★ 3.11 |
| Revenue | $12,743,000.00 | ★ $463,062,000.00 |
| Revenue This Year | $111.39 | $13.68 |
| Revenue Next Year | $235.85 | $11.32 |
| P/E Ratio | ★ N/A | $28.52 |
| Revenue Growth | ★ 87.78 | 28.39 |
| 52 Week Low | $18.56 | $65.80 |
| 52 Week High | $35.83 | $146.90 |
| Indicator | CLDX | TPB |
|---|---|---|
| Relative Strength Index (RSI) | 35.30 | 53.99 |
| Support Level | $28.30 | $83.01 |
| Resistance Level | $30.90 | $93.44 |
| Average True Range (ATR) | 1.52 | 4.84 |
| MACD | -0.48 | 0.85 |
| Stochastic Oscillator | 5.82 | 52.26 |
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Turning Point Brands Inc operates as a manufacturer, marketer, and provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum, including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments, namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.